Basel Medical vs LifeMD
BMGL and LFMD side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BMGL and LFMD compare
Basel Medical grew revenue faster over the last twelve months (45.2% versus 23.6% for LifeMD).
LifeMD keeps more of each dollar of sales as profit, with a net margin of 0.21% compared with −4.5% at Basel Medical.
LifeMD scores higher on the StockData Score (13 against 3 for Basel Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BMGL | LFMD |
|---|---|---|
| Size and price | ||
| Market cap | – | $106M |
| Share price | $0.470 | $2.19 |
| Change, 1 year | −97.2% | −56.7% |
| Change, 5 years | – | −51.7% |
| Beta (5Y) | −0.15 | 1.73 |
| Employees | 81 | 389 |
| StockData Score | ||
| Total score | 3 | 13 (better) |
| Valuation score | 0 | 3 (better) |
| Growth score | 1 | 3 (better) |
| Performance score | 1 | 3 (better) |
| Health score | 1 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 0.6× |
| FCF yield | – | −10.6% |
| Fair value | – | $2.91 |
| Margin of safety | – | 24.6% |
| Growth | ||
| Revenue growth (TTM) | 45.2% (better) | 23.6% |
| Revenue growth, 5Y average | – | 39.1% |
| Profitability | ||
| Gross margin | – | 86.5% |
| Operating margin | – | −11.0% |
| Net margin | −4.5% | 0.21% (better) |
| FCF margin | −5.4% (better) | −5.9% |
| Return on equity | – | 109% |
| Financial health | ||
| Current ratio | 1.23 (better) | 0.80 |
| Altman Z-score | – | −2.87 |
| Piotroski F-score | 4 | 5 (better) |
| Dividends and buybacks | ||
| Payout ratio | – | 776% |
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 44.9% |
| Held by insiders | – | 18.2% |
| Insider net buying, 12 months | – | −$54.1K |
Go deeper
- BMGL stock overview
- BMGL income statement
- BMGL valuation and score
- LFMD stock overview
- LFMD income statement
- LFMD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.